Approximately 85% of patients aged <45 years old will survive for at least 5 years after chemo--and/or radio--therapy (1) . Despite the gonadotoxicity of these treatments, the possibility for women to conceive a child after surviving cancer is a reality that can be envisaged thanks to advances in fertility preservation methods. Ovarian tissue cryopreservation (OTC) is one of the available options to preserve fertility before potentially sterilizing treatments (2) . Currently, frozen/thawed ovarian tissue can only be re--used by autograft, and more than twenty live births have already been reported (3, 4) . However, there is legitimate concern about the risk of cancer re--seeding by transplanting the tissue in cases of cancer (5) . In acute leukemia (AL), real--time quantitative polymerase chain reaction (RT--qPCR) (6) , or multicolor flow cytometry (MFC) based on leukemia--associated immunophenotype (LAIP) (7) can be used to identify persisting leukemic cells at low level in ovarian tissue. Two studies have investigated minimal residual disease (MRD) in ovarian tissue in the setting of acute myeloid leukemia (AML) by RT--qPCR (8, 9) . MFC makes it possible to differentiate leukemic cells from normal progenitors and hematopoietic stem cells, based on a specific LAIP profile in 95% of AML patients in bone marrow (BM) (10) . MFC has previously been used by our team to quantify MRD in the ovarian tissue of acute lymphoid leukemia (ALL) patients (11) . The objective of the current study was to develop a technique for MRD detection using 8--color flow cytometry in ovarian tissue from AML patients.
Ovarian cortical fragments, obtained by oophorectomy or biopsies, were cryopreserved using slow cooling, stored in liquid nitrogen, thawed, and then underwent mechanical and enzymatic dissociation according to previously described protocols (11 for one case where only 130000 events were acquired (range: 130000 -570000). A significant abnormal cell population was defined as a homogeneous cluster of at least 20 LAIP + events (7) . To assess the specificity of the 8 antibody combinations used and the maximum sensitivity corresponding to the limit of detection that can be achieved for MRD, a quantitative study of ovarian cells from reference ovarian tissue was performed in the same conditions. The sensitivity of the MFC method was confirmed by 10--fold serial dilutions of AML cells in reference ovarian cell suspensions (10 --1 to 10 --5 ) (11). Molecular quantification of NPM1 mutation A and CBFB--MYH11 were performed as previously described (12, 13) . ABL1
was used as housekeeping gene. 
